ITI-007

· Intra-Cellular Therapies, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ITI-007, covering 2021-06-29 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment [Phase 3]